{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T20:57:07Z","timestamp":1792270627686,"version":"4.4.0"},"reference-count":55,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T00:00:00Z","timestamp":1775606400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"NIH NIAID","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["CCSG P30 CA060553"],"award-info":[{"award-number":["CCSG P30 CA060553"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005865","name":"Mochida Memorial Foundation for Medical and Pharmaceutical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004339","name":"Sanofi US","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007185","name":"University of California, Los Angeles","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007185","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008732","name":"Uehara Memorial Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008732","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009857","name":"Regeneron Pharmaceuticals Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009857","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007059","name":"Northwestern University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007059","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"AMED","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.jaci.2026.03.021","type":"journal-article","created":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T06:52:34Z","timestamp":1775544754000},"page":"126-138","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Heterogeneity and clinical relevance of group 2 innate lymphoid cells subsets in nasal polyps"],"prefix":"10.1016","volume":"158","author":[{"given":"Masanori","family":"Kidoguchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naruhito","family":"Iwasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie A.","family":"Poposki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriko","family":"Ogasawara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiko","family":"Oka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiko I.","family":"Klingler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lydia","family":"Suh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditi","family":"Agrwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junqin","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Whitney W.","family":"Stevens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anju T.","family":"Peters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie C.","family":"Grammer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin C.","family":"Welch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie S.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micah","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amr","family":"Radwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David B.","family":"Conley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert P.","family":"Schleimer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert C.","family":"Kern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce K.","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuhiro","family":"Okano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeharu","family":"Fujieda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9144-3138","authenticated-orcid":false,"given":"Atsushi","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"suppl 1","key":"10.1016\/j.jaci.2026.03.021_bib1","first-page":"S22","article-title":"International consensus statement on allergy and rhinology: rhinosinusitis","volume":"6","author":"Orlandi","year":"2016","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.jaci.2026.03.021_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4193\/Rhin20.401","article-title":"European position paper on rhinosinusitis and nasal polyps 2020","volume":"58","author":"Fokkens","year":"2020","journal-title":"Rhinology"},{"key":"10.1016\/j.jaci.2026.03.021_bib3","doi-asserted-by":"crossref","first-page":"127","DOI":"10.2147\/JAA.S290424","article-title":"Burden of disease in chronic rhinosinusitis with nasal polyps","volume":"14","author":"Bachert","year":"2021","journal-title":"J Asthma Allergy"},{"key":"10.1016\/j.jaci.2026.03.021_bib4","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.jaip.2016.04.012","article-title":"Chronic rhinosinusitis with nasal polyps","volume":"4","author":"Stevens","year":"2016","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2026.03.021_bib5","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.jaip.2016.12.027","article-title":"Clinical characteristics of patients with chronic rhinosinusitis with nasal polyps, asthma, and aspirin-exacerbated respiratory disease","volume":"5","author":"Stevens","year":"2017","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2026.03.021_bib6","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/j.jaci.2025.03.006","article-title":"Clinical and mechanistic advancements in aspirin exacerbated respiratory disease","volume":"155","author":"Elahi","year":"2025","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.03.021_bib7","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1111\/all.15074","article-title":"Endotypes of chronic rhinosinusitis: relationships to disease phenotypes, pathogenesis, clinical findings, and treatment approaches","volume":"77","author":"Kato","year":"2022","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2026.03.021_bib8","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1111\/all.16499","article-title":"Efficacy and safety of biologics for chronic rhinosinusitis with nasal polyps: a meta-analysis of real-world evidence","volume":"80","author":"Cai","year":"2025","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2026.03.021_bib9","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/S0140-6736(19)31881-1","article-title":"Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials","volume":"394","author":"Bachert","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2026.03.021_bib10","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.jaci.2017.05.044","article-title":"Reduced need for surgery in severe nasal polyposis with mepolizumab: randomized trial","volume":"140","author":"Bachert","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.03.021_bib11","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.jaci.2020.05.032","article-title":"Efficacy and safety of omalizumab in nasal polyposis: 2 randomized phase 3 trials","volume":"146","author":"Gevaert","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.03.021_bib12","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1056\/NEJMoa2414482","article-title":"Tezepelumab in adults with severe chronic rhinosinusitis with nasal polyps","volume":"392","author":"Lipworth","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2026.03.021_bib13","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.anai.2020.08.001","article-title":"Group 2 innate lymphoid cells in nasal polyposis","volume":"126","author":"Stevens","year":"2021","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2026.03.021_bib14","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/iid3.161","article-title":"Group 2 innate lymphoid cells are elevated and activated in chronic rhinosinusitis with nasal polyps","volume":"5","author":"Poposki","year":"2017","journal-title":"Immun Inflamm Dis"},{"key":"10.1016\/j.jaci.2026.03.021_bib15","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/s41385-019-0215-8","article-title":"Role of RANK-L as a potential inducer of ILC2-mediated type 2 inflammation in chronic rhinosinusitis with nasal polyps","volume":"13","author":"Ogasawara","year":"2020","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.jaci.2026.03.021_bib16","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abd3489","article-title":"Steroid-resistant human inflammatory ILC2s are marked by CD45RO and elevated in type 2 respiratory diseases","volume":"6","author":"van der Ploeg","year":"2021","journal-title":"Sci Immunol"},{"key":"10.1016\/j.jaci.2026.03.021_bib17","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.jaci.2021.07.025","article-title":"Single-cell analysis reveals innate lymphoid cell lineage infidelity in atopic dermatitis","volume":"149","author":"Alkon","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.03.021_bib18","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1038\/s41590-022-01312-0","article-title":"Single-cell profiling identifies mechanisms of inflammatory heterogeneity in chronic rhinosinusitis","volume":"23","author":"Wang","year":"2022","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaci.2026.03.021_bib19","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abg6356","article-title":"Single-cell analysis pinpoints distinct populations of cytotoxic CD4+ T cells and an IL-10+CD109+ TH2 cell population in nasal polyps","volume":"6","author":"Ma","year":"2021","journal-title":"Sci Immunol"},{"key":"10.1016\/j.jaci.2026.03.021_bib20","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1038\/s41586-019-0969-x","article-title":"The single-cell transcriptional landscape of mammalian organogenesis","volume":"566","author":"Cao","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2026.03.021_bib21","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.immuni.2012.12.003","article-title":"T cell factor 1 is required for group 2 innate lymphoid cell generation","volume":"38","author":"Yang","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2026.03.021_bib22","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aay4218","article-title":"Human innate lymphoid cell precursors express CD48 that modulates ILC differentiation through 2B4 signaling","volume":"5","author":"Tufa","year":"2020","journal-title":"Sci Immunol"},{"key":"10.1016\/j.jaci.2026.03.021_bib23","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1038\/s41590-024-01885-y","article-title":"Diversity of group 1 innate lymphoid cells in human tissues","volume":"25","author":"Jaeger","year":"2024","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaci.2026.03.021_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1374828","article-title":"Single cell multi-omic analysis identifies key genes differentially expressed in innate lymphoid cells from COVID-19 patients","volume":"15","author":"Kaushik","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2026.03.021_bib25","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1126\/science.aam5809","article-title":"S1P-dependent interorgan trafficking of group 2 innate lymphoid cells supports host defense","volume":"359","author":"Huang","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.jaci.2026.03.021_bib26","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/s41467-019-08365-0","article-title":"Runx\/Cbfbeta complexes protect group 2 innate lymphoid cells from exhausted-like hyporesponsiveness during allergic airway inflammation","volume":"10","author":"Miyamoto","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.jaci.2026.03.021_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtemb.2021.126712","article-title":"COMMD1, a multi-potent intracellular protein involved in copper homeostasis, protein trafficking, inflammation, and cancer","volume":"65","author":"Weiskirchen","year":"2021","journal-title":"J Trace Elem Med Biol"},{"key":"10.1016\/j.jaci.2026.03.021_bib28","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/cea.14003","article-title":"Contribution of dipeptidyl peptidase 10 to airway dysfunction in patients with NSAID-exacerbated respiratory disease","volume":"52","author":"Sim","year":"2022","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2026.03.021_bib29","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1038\/s41590-024-01803-2","article-title":"TCF1-LEF1 co-expression identifies a multipotent progenitor cell (TH2-MPP) across human allergic diseases","volume":"25","author":"Kratchmarov","year":"2024","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaci.2026.03.021_bib30","doi-asserted-by":"crossref","first-page":"800","DOI":"10.7150\/ijbs.65457","article-title":"Role of RHO family interacting cell polarization regulators (RIPORs) in health and disease: recent advances and prospects","volume":"18","author":"Lv","year":"2022","journal-title":"Int J Biol Sci"},{"key":"10.1016\/j.jaci.2026.03.021_bib31","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1038\/s41385-021-00431-5","article-title":"Tissue signals imprint Aiolos expression in ILC2s to modulate type 2 immunity","volume":"14","author":"Qiu","year":"2021","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.jaci.2026.03.021_bib32","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/s41420-024-02096-y","article-title":"Tissue microenvironment induces tissue specificity of ILC2","volume":"10","author":"Qin","year":"2024","journal-title":"Cell Death Discov"},{"key":"10.1016\/j.jaci.2026.03.021_bib33","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/s41577-025-01159-0","article-title":"The immunology of asthma and chronic rhinosinusitis","volume":"25","author":"Kato","year":"2025","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaci.2026.03.021_bib34","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu-13-886520","article-title":"Plasticity of innate lymphoid cells in cancer","volume":"13","author":"Heinrich","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2026.03.021_bib35","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/s42003-023-05536-0","article-title":"A diversity of novel type-2 innate lymphoid cell subpopulations revealed during tumour expansion","volume":"7","author":"Xia","year":"2024","journal-title":"Commun Biol"},{"key":"10.1016\/j.jaci.2026.03.021_bib36","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/j.cell.2014.03.065","article-title":"Meteorin-like is a hormone that regulates immune\u2013adipose interactions to increase beige fat thermogenesis","volume":"157","author":"Rao","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.jaci.2026.03.021_bib37","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1016\/j.jaci.2022.02.016","article-title":"Mechanisms and pathogenesis of chronic rhinosinusitis","volume":"149","author":"Kato","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.03.021_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2021.155594","article-title":"The tumor necrosis factor family molecules LIGHT and lymphotoxins in sinus mucosa of patients with chronic rhinosinusitis with or without nasal polyps","volume":"148","author":"Hwang","year":"2021","journal-title":"Cytokine"},{"key":"10.1016\/j.jaci.2026.03.021_bib39","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/9798206","article-title":"Th17 cytokines disrupt the airway mucosal barrier in chronic rhinosinusitis","volume":"2016","author":"Ramezanpour","year":"2016","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.jaci.2026.03.021_bib40","first-page":"1558","article-title":"AREG mediates the epithelial\u2013mesenchymal transition in pancreatic cancer cells via the EGFR\/ERK\/NF-kappaB signalling pathway","volume":"43","author":"Wang","year":"2020","journal-title":"Oncol Rep"},{"key":"10.1016\/j.jaci.2026.03.021_bib41","doi-asserted-by":"crossref","first-page":"3777","DOI":"10.18632\/oncotarget.6756","article-title":"Leukemia inhibitory factor promotes EMT through STAT3-dependent miR-21 induction","volume":"7","author":"Yue","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.jaci.2026.03.021_bib42","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1038\/s41590-022-01337-5","article-title":"Divergent clonal differentiation trajectories of T cell exhaustion","volume":"23","author":"Daniel","year":"2022","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaci.2026.03.021_bib43","doi-asserted-by":"crossref","first-page":"263","DOI":"10.3390\/cancers17020263","article-title":"Multiple myeloma cells shift the fate of cytolytic ILC2s towards TIGIT-mediated cell death","volume":"17","author":"Drommi","year":"2025","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jaci.2026.03.021_bib44","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20222005","article-title":"TIGIT mediates activation-induced cell death of ILC2s during chronic airway allergy","volume":"220","author":"Yamada","year":"2023","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2026.03.021_bib45","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.3390\/ijms20061377","article-title":"Transcription factors in the development and function of group 2 innate lymphoid cells","volume":"20","author":"Ebihara","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jaci.2026.03.021_bib46","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.immuni.2015.02.007","article-title":"ICOS:ICOS\u2013ligand interaction is required for type 2 innate lymphoid cell function, homeostasis, and induction of airway hyperreactivity","volume":"42","author":"Maazi","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2026.03.021_bib47","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1016\/j.jaci.2024.12.1097","article-title":"ICOSL, OX40L, and CD30L control persistence of asthmatic CD4 tissue-resident memory CD4 T cells","volume":"155","author":"Sethi","year":"2025","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.03.021_bib48","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20231827","article-title":"Human CD127 negative ILC2s show immunological memory","volume":"221","author":"Matha","year":"2024","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2026.03.021_bib49","doi-asserted-by":"crossref","first-page":"7108","DOI":"10.1038\/s41467-025-62532-0","article-title":"TLR4+ group 2 innate lymphoid cells contribute to persistent type 2 immunity in airway diseases","volume":"16","author":"Li","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.jaci.2026.03.021_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlr.2023.100486","article-title":"25-Hydroxycholesterol in health and diseases","volume":"65","author":"Nguyen","year":"2024","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jaci.2026.03.021_bib51","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1268756","article-title":"Extracellular nicotinamide phosphoribosyltransferase: role in disease pathophysiology and as a biomarker","volume":"14","author":"Semerena","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2026.03.021_bib52","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2015.162","article-title":"T-cell exhaustion in the tumor microenvironment","volume":"6","author":"Jiang","year":"2015","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.jaci.2026.03.021_bib53","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.jaci.2017.09.025","article-title":"IL-10, TGF-beta, and glucocorticoid prevent the production of type 2 cytokines in human group 2 innate lymphoid cells","volume":"141","author":"Ogasawara","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.03.021_bib54","doi-asserted-by":"crossref","first-page":"3265","DOI":"10.1111\/all.15877","article-title":"Inflammatory innate lymphoid cells predict response speed to dupilumab in chronic rhinosinusitis with nasal polyps","volume":"78","author":"Golebski","year":"2023","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2026.03.021_bib55","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.jaci.2020.01.038","article-title":"Optimal identification of human conventional and nonconventional (CRTH2\u2212IL7Ralpha\u2212) ILC2s using additional surface markers","volume":"146","author":"Liu","year":"2020","journal-title":"J Allergy Clin Immunol"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674926002526?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674926002526?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T22:10:26Z","timestamp":1786486226000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674926002526"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S0091674926002526"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2026.03.021","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Heterogeneity and clinical relevance of group 2 innate lymphoid cells subsets in nasal polyps","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2026.03.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology.","name":"copyright","label":"Copyright"}]}}